PPARGC1A and inflammatory bowel disease: This research study considers the Celastrol stimulating effect on PGC-1α expression, promoting antioxidant enzymes that can protect intestinal cells against ROS and reduce the incidence of apoptosis, ameliorating the disease manifestations in IBD subjects [48].